China’s Xi speaks with Trump by phone, discusses Taiwan and bilateral ties
SANTA CLARA - Agilent Technologies Inc. (NYSE:A) announced Tuesday it will pay a quarterly dividend of 25.5 cents per share of common stock on January 28, 2026, to shareholders of record as of January 6, 2026. This continues the company's 14-year streak of maintaining dividend payments, with the current annual dividend yield standing at 0.69%.
The laboratory technologies company noted in a press release that future dividend timing and amounts remain subject to determination and approval by its board of directors. The company has demonstrated consistent dividend growth, with a 5.08% increase in the last twelve months.
Agilent, which provides analytical and clinical laboratory technologies, reported revenue of $6.79 billion in the last twelve months and employs approximately 18,000 people worldwide. The company currently trades at a P/E ratio of 33.84 and has a market capitalization of $41.06 billion.
The company's dividend announcement comes as part of its regular shareholder return program. Agilent's statement included standard forward-looking disclaimers noting that future dividend obligations involve risks and uncertainties that could cause results to differ from current expectations.
Agilent Technologies develops and manufactures instruments, software, services and solutions for laboratory analysis across various industries.
In other recent news, Agilent Technologies has announced a quarterly dividend of 25.5 cents per share, payable on January 28, 2026, to shareholders on record as of January 6, 2026. The company also appointed Adam S. Elinoff as its new chief financial officer, effective November 17. Elinoff brings extensive experience from his previous role at Amgen, where he served as vice president of finance and treasurer. Additionally, Rothschild Redburn has initiated coverage of Agilent with a Buy rating and a price target of $165. UBS has upgraded Agilent from Neutral to Buy, raising the price target to $170, citing the company's growth leadership potential. The firm highlighted Agilent's recent launches in liquid chromatography and LC/MS instruments as key growth vectors. Meanwhile, Crawford & Company has increased its share repurchase program by 2 million shares, extending its termination date to December 31, 2027. These developments reflect significant corporate actions and analyst perspectives impacting the companies.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.